PCI Pharma Services

PCI Pharma Services is a leading global Contract Development and Manufacturing Organization (CDMO) providing integrated pharmaceutical development, manufacturing, packaging, and commercialization services. Founded in 1971 and headquartered in Philadelphia, Pennsylvania, USA, the company supports pharmaceutical, biotechnology, and specialty pharmaceutical companies throughout the entire product lifecycle—from early clinical development to commercial launch and global distribution.

PCI Pharma Services specializes in formulation development, sterile fill-finish manufacturing, lyophilization, biologics manufacturing support, clinical trial services, pharmaceutical packaging, serialization, cold chain logistics, and commercial supply. The company is particularly recognized for its expertise in advanced drug delivery systems, injectable medicines, biologics, vaccines, and cell & gene therapy support.

Operating more than 30 facilities across North America, Europe, and Asia-Pacific, PCI maintains a global network designed to meet the highest international quality and regulatory standards. Its manufacturing sites are regularly inspected by regulatory authorities including the US FDA, EMA, MHRA, and other international agencies. Through continuous investment in automation, digital technologies, sustainability, and scientific innovation, PCI Pharma Services has become a trusted strategic partner for many of the world’s leading pharmaceutical and biotechnology companies.